galantamine and Dementia, Vascular

galantamine has been researched along with Dementia, Vascular in 54 studies

Research

Studies (54)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	48 (88.89)	29.6817
2010's	4 (7.41)	24.3611
2020's	2 (3.70)	2.80

Authors

Authors	Studies
Barkhof, F; Groeneveld, GJ; Klaassen, ES; Leeuwis, AE; Leijenaar, JF; Prins, ND; Scheltens, P; van der Flier, WM; van Gerven, JMA; Weinstein, HC	1
Abdul-Rahim, AH; Battle, CE; Hewitt, J; Quinn, TJ; Shenkin, SD	1
Johnell, K; Sonde, L	1
Arizaga, RL; Demey, I; Rojas, G	1
Birks, J; Craig, D	2
Aarsland, D; Auestad, B; Bloniecki, V; Freund-Levi, Y; Lärksäter, M; Tysen Bäckström, AC	1
Chen, YD; Hu, WL; Wang, Y; Yuan, JL; Zhang, J	1
Tang, XC; Wang, J; Zhang, HY	1
Mokhova, OI	1
Damulin, IV	1
Marder, K	1
Erkinjuntti, T	3
Kertesz, A	1
Geerts, H; Grantham, C	1
van Gool, WA	1
Antonello, RM; Bava, A; Cazzato, G; Moretti, R; Torre, P	1
Kurz, A	2
Kurz, A; Lilienfeld, S	1
Small, GW	1
Bowler, JV	1
Corey-Bloom, J	1
McKeith, I	1
Bullock, R; Damaraju, CV; Erkinjuntti, T; Kurz, A; Lilienfeld, S; Small, GW	1
Erkinjuntti, T; Kurz, A; Lilienfeld, S; Small, G	1
Bonelli, RM	1
Bullock, R; Erkinjuntti, T; Lilienfeld, S	1
Fuchsberger, T; Hampel, H; Möller, HJ	1
Damaraju, CR; Erkinjuntti, T; Kurz, AF; Lilienfeld, S; Small, GW	1
Gavrilova, SI; Zharikov, GA	1
Erkinjuntti, T; Feldman, H; Gauthier, S; Rockwood, K; Román, G	1
Erkinjuntti, T; Gauthier, S; Román, G	1
Bullock, R	1
Brashear, HR	1
Lemeshko, ID; Mazal'skaia, OV; Petrukhin, AS; Pylaeva, OA; Voronkova, KV	1
Gállego Pérez-Larraya, J; Irimia, P; Martínez-Vila, E; Murie-Fernández, M	1
Chankrachang, S; Nidhinandana, S; Phanthumchinda, K; Poungvarin, N; Praditsuwan, R; Senanarong, V; Thavichachart, N	1
Duaso, E; Formiga, F; Fort, I; Pérez-Castejón, JM; Riu, S; Ruiz, D	1
Johannsen, P	1
Farlow, MR	1
Auchus, AP; Brashear, HR; De Deyn, PP; Gassmann-Mayer, C; Korczyn, AD; Salloway, S	1
Kavirajan, H; Schneider, LS	1
Bär, KJ; Boettger, MK; Mentzel, HJ; Sauer, H; Seidler, N; Terborg, C	1
Gorelick, PB; Nyenhuis, DL	1
Landmark, K; Reikvam, A	1
Small, G	1
Maelicke, A	1
Schneider, LS	1
Bullock, R; Damaraju, CV; Erkinjuntti, T; Gauthier, S; Kurz, A; Lilienfeld, S	1
Garrido Barral, A; González Moneo, MJ	1

Reviews

20 review(s) available for galantamine and Dementia, Vascular

Article	Year
Cholinesterase inhibitors for vascular dementia and other vascular cognitive impairments: a network meta-analysis. The Cochrane database of systematic reviews, 2021, 02-22, Volume: 2 Topics: Activities of Daily Living; Bias; Cholinesterase Inhibitors; Cognition; Dementia, Vascular; Donepezil; Galantamine; Humans; Network Meta-Analysis; Nootropic Agents; Physical Functional Performance; Placebos; Randomized Controlled Trials as Topic; Rivastigmine	2021
Galantamine for vascular cognitive impairment. The Cochrane database of systematic reviews, 2006, Jan-25, Issue:4 Topics: Alzheimer Disease; Cholinesterase Inhibitors; Cognition Disorders; Dementia, Vascular; Galantamine; Humans; Nootropic Agents; Randomized Controlled Trials as Topic	2006
Efficacy of Cholinesterase Inhibitors in Vascular Dementia: An Updated Meta-Analysis. European neurology, 2016, Volume: 75, Issue:3-4 Topics: Aged; Aged, 80 and over; Cholinesterase Inhibitors; Dementia, Vascular; Donepezil; Female; Galantamine; Humans; Indans; Neuropsychological Tests; Piperidines; Rivastigmine	2016
Cholinergic deficiency involved in vascular dementia: possible mechanism and strategy of treatment. Acta pharmacologica Sinica, 2009, Volume: 30, Issue:7 Topics: Acetylcholine; Alkaloids; Animals; Anti-Inflammatory Agents; Cholinergic Agents; Cholinesterase Inhibitors; Dementia, Vascular; Disease Models, Animal; Donepezil; Galantamine; Humans; Indans; Inflammation; Neuroprotective Agents; Nootropic Agents; Phenylcarbamates; Piperidines; Receptors, Cholinergic; Rivastigmine; Sesquiterpenes; Signal Transduction	2009
Treatment options: the latest evidence with galantamine (Reminyl). Journal of the neurological sciences, 2002, Nov-15, Volume: 203-204 Topics: Alzheimer Disease; Cerebrovascular Disorders; Dementia, Vascular; Endpoint Determination; Galantamine; Humans; Multicenter Studies as Topic; Nootropic Agents; Randomized Controlled Trials as Topic	2002
The rationale behind cholinergic drug treatment for dementia related to cerebrovascular disease. Journal of the neurological sciences, 2002, Nov-15, Volume: 203-204 Topics: Aged; Cerebrovascular Disorders; Cholinergic Agents; Clinical Trials as Topic; Dementia, Vascular; Galantamine; Humans; Parasympathetic Nervous System; Synaptic Transmission	2002
A novel treatment for patients with Alzheimer's disease and with vascular dementia. Annals of the New York Academy of Sciences, 2002, Volume: 977 Topics: Alzheimer Disease; Cholinesterase Inhibitors; Clinical Trials as Topic; Dementia, Vascular; Galantamine; Humans; Phytotherapy	2002
Galantamine: a review of its use in Alzheimer's disease and vascular dementia. International journal of clinical practice, 2003, Volume: 57, Issue:3 Topics: Alzheimer Disease; Cholinesterase Inhibitors; Dementia, Vascular; Galantamine; Humans	2003
[Current therapy of patients with dementia]. MMW Fortschritte der Medizin, 2003, May-26, Volume: 145 Suppl 2 Topics: Activities of Daily Living; Alzheimer Disease; Carbamates; Cholinesterase Inhibitors; Controlled Clinical Trials as Topic; Dementia; Dementia, Vascular; Donepezil; Dopamine Agents; Female; Galantamine; Ginkgo biloba; Humans; Indans; Male; Memantine; Meta-Analysis as Topic; Multicenter Studies as Topic; Neuroprotective Agents; Nootropic Agents; Phenylcarbamates; Phytotherapy; Piperidines; Placebos; Plant Preparations; Prospective Studies; Rivastigmine; Tacrine; Time Factors	2003
[Galantamine (reminyl) in the treatment of Alzheimer's disease and vascular dementia]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2003, Volume: 103, Issue:12 Topics: Alzheimer Disease; Cholinesterase Inhibitors; Clinical Trials as Topic; Dementia, Vascular; Drug Therapy, Combination; Galantamine; Humans; Treatment Outcome	2003
Treatment of vascular dementia--evidence from clinical trials with cholinesterase inhibitors. Journal of the neurological sciences, 2004, Nov-15, Volume: 226, Issue:1-2 Topics: Aged; Cholinesterase Inhibitors; Clinical Trials as Topic; Dementia, Vascular; Donepezil; Galantamine; Humans; Indans; Nootropic Agents; Parasympathetic Nervous System; Phenylcarbamates; Piperidines; Rivastigmine	2004
Galantamine: use in Alzheimer's disease and related disorders. Expert review of neurotherapeutics, 2004, Volume: 4, Issue:2 Topics: Alzheimer Disease; Cholinesterase Inhibitors; Dementia, Vascular; Galantamine; Humans	2004
Galantamine for vascular cognitive impairment. The Cochrane database of systematic reviews, 2006, Jan-25, Issue:1 Topics: Alzheimer Disease; Cholinesterase Inhibitors; Cognition Disorders; Dementia, Vascular; Galantamine; Humans; Nootropic Agents; Randomized Controlled Trials as Topic	2006
[Medical treatment of Alzheimer's disease]. Ugeskrift for laeger, 2006, Oct-02, Volume: 168, Issue:40 Topics: Activities of Daily Living; Alzheimer Disease; Cholinesterase Inhibitors; Clinical Trials as Topic; Cognition; Dementia, Vascular; Disease Progression; Donepezil; Evidence-Based Medicine; Galantamine; Humans; Indans; Lewy Body Disease; Memantine; Nootropic Agents; Parkinson Disease; Phenylcarbamates; Piperidines; Randomized Controlled Trials as Topic; Rivastigmine; Treatment Outcome	2006
Use of antidementia agents in vascular dementia: beyond Alzheimer disease. Mayo Clinic proceedings, 2006, Volume: 81, Issue:10 Topics: Cholinesterase Inhibitors; Dementia, Vascular; Diagnosis, Differential; Donepezil; Dopamine Agents; Galantamine; Humans; Indans; Memantine; Phenylcarbamates; Piperidines; Receptors, N-Methyl-D-Aspartate; Rivastigmine; Stroke	2006
Efficacy and adverse effects of cholinesterase inhibitors and memantine in vascular dementia: a meta-analysis of randomised controlled trials. The Lancet. Neurology, 2007, Volume: 6, Issue:9 Topics: Cholinesterase Inhibitors; Databases, Bibliographic; Dementia, Vascular; Donepezil; Dose-Response Relationship, Drug; Double-Blind Method; Drug Evaluation; Excitatory Amino Acid Antagonists; Galantamine; Humans; Indans; Memantine; Odds Ratio; Phenylcarbamates; Piperidines; Randomized Controlled Trials as Topic; Rivastigmine; Time Factors; Treatment Outcome	2007
Diagnosis and management of vascular cognitive impairment. Current atherosclerosis reports, 2007, Volume: 9, Issue:4 Topics: Central Nervous System Agents; Clinical Trials as Topic; Cognition Disorders; Dementia, Vascular; Donepezil; Galantamine; Humans; Indans; Memantine; Phenylcarbamates; Piperidines; Risk Factors; Rivastigmine	2007
[Cholinesterase inhibitors in the treatment of dementia--are they useful in clinical practice?]. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 2008, Jan-31, Volume: 128, Issue:3 Topics: Alzheimer Disease; Cholinesterase Inhibitors; Dementia; Dementia, Vascular; Donepezil; Evidence-Based Medicine; Galantamine; Humans; Indans; Lewy Body Disease; Phenylcarbamates; Piperidines; Rivastigmine; Time Factors; Treatment Outcome	2008
The pharmacological rationale for treating vascular dementia with galantamine (Reminyl). International journal of clinical practice. Supplement, 2001, Issue:120 Topics: Acetylcholine; Alzheimer Disease; Cholinesterase Inhibitors; Dementia, Vascular; Galantamine; Humans; Nootropic Agents; Receptors, Cholinergic; Receptors, Nicotinic	2001
[Latest therapies for treating dementia]. Atencion primaria, 2002, May-15, Volume: 29, Issue:8 Topics: Adult; Aged; Alzheimer Disease; Amitriptyline; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Clinical Trials as Topic; Cognition; Cohort Studies; Controlled Clinical Trials as Topic; Dementia, Vascular; Donepezil; Female; Fluoxetine; Galantamine; Haloperidol; Hormone Replacement Therapy; Humans; Hydroxychloroquine; Indans; Middle Aged; Nootropic Agents; Piperidines; Placebos; Practice Guidelines as Topic; Quality of Life; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Time Factors; Trazodone	2002

Trials

11 trial(s) available for galantamine and Dementia, Vascular

Article	Year
Methylphenidate and galantamine in patients with vascular cognitive impairment-the proof-of-principle study STREAM-VCI. Alzheimer's research & therapy, 2020, 01-07, Volume: 12, Issue:1 Topics: Aged; Central Nervous System Stimulants; Cognitive Dysfunction; Cross-Over Studies; Dementia, Vascular; Double-Blind Method; Executive Function; Female; Galantamine; Humans; Male; Memory; Methylphenidate; Middle Aged; Nootropic Agents; Proof of Concept Study	2020
Galantamine versus risperidone for agitation in people with dementia: a randomized, twelve-week, single-center study. Dementia and geriatric cognitive disorders, 2014, Volume: 38, Issue:3-4 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Antipsychotic Agents; Dementia; Dementia, Vascular; Female; Galantamine; Humans; Male; Nootropic Agents; Psychomotor Agitation; Risperidone; Treatment Outcome	2014
Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomized trial. Current neurology and neuroscience reports, 2002, Volume: 2, Issue:5 Topics: Alzheimer Disease; Cerebrovascular Disorders; Cholinesterase Inhibitors; Cognition; Dementia, Vascular; Double-Blind Method; Galantamine; Humans; Treatment Outcome	2002
Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomized trial. Current neurology and neuroscience reports, 2002, Volume: 2, Issue:6 Topics: Alzheimer Disease; Cerebrovascular Disorders; Cholinesterase Inhibitors; Dementia, Vascular; Double-Blind Method; Galantamine; Humans; Nausea; Psychiatric Status Rating Scales; Severity of Illness Index; Treatment Outcome; Vomiting	2002
An open-label extension trial of galantamine in patients with probable vascular dementia and mixed dementia. Clinical therapeutics, 2003, Volume: 25, Issue:6 Topics: Aged; Alzheimer Disease; Cerebrovascular Disorders; Cholinesterase Inhibitors; Cognition; Dementia, Vascular; Double-Blind Method; Female; Galantamine; Humans; Male	2003
Galantamine in the treatment of cognitive decline in patients with vascular dementia or Alzheimer's disease with cerebrovascular disease. CNS drugs, 2003, Volume: 17, Issue:12 Topics: Aged; Alzheimer Disease; Cerebrovascular Disorders; Cholinesterase Inhibitors; Cognition; Dementia, Vascular; Double-Blind Method; Female; Galantamine; Humans; Male; Psychiatric Status Rating Scales; Treatment Outcome	2003
Management of patients with Alzheimer's disease plus cerebrovascular disease: 12-month treatment with galantamine. Dementia and geriatric cognitive disorders, 2004, Volume: 17, Issue:1-2 Topics: Aged; Alzheimer Disease; Dementia, Vascular; Female; Galantamine; Humans; Male; Nootropic Agents; Quality of Life; Treatment Outcome	2004
Long-term safety and cognitive effects of galantamine in the treatment of probable vascular dementia or Alzheimer's disease with cerebrovascular disease. European journal of neurology, 2003, Volume: 10, Issue:6 Topics: Aged; Alzheimer Disease; Cerebrovascular Disorders; Cholinesterase Inhibitors; Cognition; Dementia, Vascular; Double-Blind Method; Electrocardiography; Female; Follow-Up Studies; Galantamine; Humans; Male; Neuropsychological Tests	2003
Efficacy study of galantamine in possible Alzheimer's disease with or without cerebrovascular disease and vascular dementia in Thai patients: a slow-titration regimen. International journal of clinical practice, 2006, Volume: 60, Issue:5 Topics: Aged; Alzheimer Disease; Cerebrovascular Disorders; Cholinesterase Inhibitors; Dementia, Vascular; Drug Administration Schedule; Female; Galantamine; Humans; Male; Nootropic Agents; Treatment Outcome	2006
Galantamine treatment of vascular dementia: a randomized trial. Neurology, 2007, Jul-31, Volume: 69, Issue:5 Topics: Acetylcholine; Activities of Daily Living; Adult; Aged; Behavioral Symptoms; Brain; Brain Chemistry; Cholinesterase Inhibitors; Cognition; Cognition Disorders; Dementia, Vascular; Double-Blind Method; Female; Galantamine; Humans; Male; Middle Aged; Neuropsychological Tests; Placebos; Recovery of Function; Treatment Outcome	2007
Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomised trial. Lancet (London, England), 2002, Apr-13, Volume: 359, Issue:9314 Topics: Aged; Alzheimer Disease; Cerebrovascular Disorders; Cholinesterase Inhibitors; Cognition; Dementia, Vascular; Double-Blind Method; Female; Galantamine; Humans; Male; Treatment Outcome	2002

Other Studies

23 other study(ies) available for galantamine and Dementia, Vascular

Article	Year
Is drug treatment for dementia followed up in primary care? A Swedish study of dementia clinics and referring primary care centres. PloS one, 2013, Volume: 8, Issue:2 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Dementia; Dementia, Vascular; Donepezil; Female; Galantamine; Humans; Indans; Male; Medical Records; Memantine; Nootropic Agents; Phenylcarbamates; Piperidines; Practice Guidelines as Topic; Practice Patterns, Physicians'; Primary Health Care; Retrospective Studies; Rivastigmine; Sweden; Treatment Outcome	2013
[Drugs used for cognitive impairment. Analysis of 1.5 million prescriptions in Argentina]. Medicina, 2013, Volume: 73, Issue:3 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Argentina; Child; Child, Preschool; Cholinesterase Inhibitors; Cognition Disorders; Dementia; Dementia, Vascular; Donepezil; Drug Prescriptions; Female; Galantamine; Humans; Indans; Infant; Male; Memantine; Middle Aged; Phenylcarbamates; Piperidines; Retrospective Studies; Rivastigmine; Young Adult	2013
[The use of reminyl (galantamine) in the treatment of probable vascular dementia]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2009, Volume: 109, Issue:9 Topics: Activities of Daily Living; Aged; Aged, 80 and over; Cognition; Dementia, Vascular; Diagnosis, Differential; Female; Follow-Up Studies; Galantamine; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Nootropic Agents; Time Factors; Treatment Outcome	2009
[The use of galantamine in Alzheimer's disease associated with vascular dementia (according to the study of T. Erkinjuntti group)]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2009, Volume: 109, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Alzheimer Disease; Cholinesterase Inhibitors; Data Interpretation, Statistical; Dementia, Vascular; Double-Blind Method; Female; Galantamine; Humans; Male; Middle Aged; Nootropic Agents; Placebos; Randomized Controlled Trials as Topic; Risk Factors; Time Factors; Treatment Outcome	2009
Broad therapeutic benefits in patients with probable vascular dementia or Alzheimer's disease with cerebrovascular disease after treatment with galantamine. European journal of neurology, 2002, Volume: 9, Issue:5 Topics: Activities of Daily Living; Alzheimer Disease; Cholinesterase Inhibitors; Cognition; Dementia, Vascular; Galantamine; Humans; Treatment Outcome	2002
Use of galantamine to treat vascular dementia. Lancet (London, England), 2002, Nov-09, Volume: 360, Issue:9344 Topics: Cholinesterase Inhibitors; Dementia, Vascular; Galantamine; Humans; Nootropic Agents	2002
Use of galantamine to treat vascular dementia. Lancet (London, England), 2002, Nov-09, Volume: 360, Issue:9344 Topics: Cholinesterase Inhibitors; Dementia, Vascular; Galantamine; Humans; Nootropic Agents	2002
Broad therapeutic benefits in patients with probable vascular dementia or Alzheimer's disease with cerebrovascular disease treated with galantamine. Annals of the New York Academy of Sciences, 2002, Volume: 977 Topics: Alzheimer Disease; Cholinesterase Inhibitors; Clinical Trials as Topic; Dementia, Vascular; Galantamine; Humans; Phytotherapy; Research Design; Time Factors	2002
Vascular dementia: galantamine (Reminyl) as an emerging therapeutic option. Acta neurologica Scandinavica. Supplementum, 2002, Volume: 178 Topics: Anticholesteremic Agents; Dementia, Vascular; Galantamine; Humans; Nootropic Agents	2002
Cognitive decline and treatment options for patients with vascular dementia. Acta neurologica Scandinavica. Supplementum, 2002, Volume: 178 Topics: Aged; Cholinesterase Inhibitors; Cognition Disorders; Dementia, Vascular; Diagnosis, Differential; Galantamine; Humans; Neuropsychological Tests; Nootropic Agents; Treatment Outcome	2002
Non-cognitive benefits of galantamine (Reminyl) treatment in vascular dementia. Acta neurologica Scandinavica. Supplementum, 2002, Volume: 178 Topics: Activities of Daily Living; Aged; Cholinesterase Inhibitors; Clinical Trials as Topic; Dementia, Vascular; Galantamine; Humans; Neuropsychological Tests; Nootropic Agents; Quality of Life; Social Behavior; Treatment Outcome	2002
Acetylcholinesterase inhibitors for vascular dementia and Alzheimer's disease combined with cerebrovascular disease. Stroke, 2003, Volume: 34, Issue:2 Topics: Alzheimer Disease; Cerebrovascular Disorders; Cholinesterase Inhibitors; Cognition Disorders; Dementia, Vascular; Diagnosis, Differential; Donepezil; Galantamine; Humans; Indans; Neuropsychological Tests; Nootropic Agents; Piperidines; Severity of Illness Index; Terminology as Topic; Treatment Outcome	2003
Galantamine for vascular dementia. The Lancet. Neurology, 2002, Volume: 1, Issue:4 Topics: Cholinesterase Inhibitors; Dementia, Vascular; Galantamine; Humans	2002
Editorial comment--How to treat vascular dementia? Stroke, 2003, Volume: 34, Issue:10 Topics: Carbamates; Cholinesterase Inhibitors; Clinical Trials as Topic; Dementia, Vascular; Donepezil; Galantamine; Humans; Indans; Memantine; Nootropic Agents; Phenylcarbamates; Piperidines; Receptors, N-Methyl-D-Aspartate; Rivastigmine; Treatment Outcome	2003
Emerging therapies for vascular dementia and vascular cognitive impairment. Stroke, 2004, Volume: 35, Issue:4 Topics: Carbamates; Cardiovascular Diseases; Cerebrovascular Disorders; Cholinesterase Inhibitors; Cognition Disorders; Controlled Clinical Trials as Topic; Dementia, Vascular; Donepezil; Galantamine; Humans; Indans; Phenylcarbamates; Piperidines; Risk Factors; Rivastigmine; Stroke; Terminology as Topic	2004
Galantamine in the treatment of vascular dementia. International psychogeriatrics, 2003, Volume: 15 Suppl 1 Topics: Aged; Alzheimer Disease; Cholinesterase Inhibitors; Cognition Disorders; Dementia, Vascular; Galantamine; Humans	2003
[Traditional dementia concepts in transition--must we change our views?]. Der Nervenarzt, 2005, Volume: 76, Issue:9 Topics: Dementia, Vascular; Galantamine; Humans; Nootropic Agents; Practice Guidelines as Topic; Practice Patterns, Physicians'; Treatment Outcome	2005
[Use of reminyl (galantamine) in the treatment of dementia]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2006, Volume: 106, Issue:3 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cholinesterase Inhibitors; Dementia; Dementia, Vascular; Female; Galantamine; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Time Factors; Treatment Outcome	2006
Neuroprotection in vascular dementia. Cerebrovascular diseases (Basel, Switzerland), 2006, Volume: 21 Suppl 2 Topics: Animals; Cholinesterase Inhibitors; Dementia, Vascular; Donepezil; Excitatory Amino Acid Antagonists; Galantamine; Heart Diseases; Humans; Hypercholesterolemia; Hypertension; Indans; Memantine; Neuroprotective Agents; Patient Selection; Piperidines; Randomized Controlled Trials as Topic; Research Design; Risk Factors; Stroke	2006
[Risperidone and cerebrovascular adverse effects in elderly patients with dementia]. Revista clinica espanola, 2006, Volume: 206, Issue:8 Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Cerebrovascular Disorders; Cholinesterase Inhibitors; Dementia, Vascular; Donepezil; Female; Galantamine; Humans; Indans; Male; Piperidines; Risperidone	2006
Influence of galantamine on vasomotor reactivity in Alzheimer's disease and vascular dementia due to cerebral microangiopathy. Stroke, 2007, Volume: 38, Issue:12 Topics: Acetylcholinesterase; Adult; Aged; Alzheimer Disease; Carbon Dioxide; Case-Control Studies; Cerebrovascular Disorders; Cholinesterase Inhibitors; Dementia, Vascular; Female; Galantamine; Humans; Male; Middle Aged; Nervous System; Spectroscopy, Near-Infrared; Ultrasonography, Doppler	2007
Meeting the challenges of vascular dementia. Introduction. International journal of clinical practice. Supplement, 2001, Issue:120 Topics: Alzheimer Disease; Dementia, Vascular; Galantamine; Humans; Nootropic Agents	2001
Galantamine for vascular dementia: some answers, some questions. Lancet (London, England), 2002, Apr-13, Volume: 359, Issue:9314 Topics: Alzheimer Disease; Cholinesterase Inhibitors; Cognition; Dementia, Vascular; Galantamine; Humans; Treatment Outcome	2002